Author:
Damiani Roberto Marques,Moura Dinara Jaqueline,Viau Cassiana Macagnan,Caceres Rafael Andrade,Henriques João Antonio Pêgas,Saffi Jenifer
Funder
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul
Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Toxicology,General Medicine
Reference120 articles.
1. Adachi K, Fujiura Y, Mayumi F et al (1993) A deletion of mitochondrial DNA in murine doxorubicin-induced cardiotoxicity. Biochem Biophys Res Commun 195:945–951. doi:
10.1006/bbrc.1993.2135
2. Alderton PM, Gross J, Green MD (1992) Comparative study of doxorubicin, mitoxantrone, and epirubicin in combination with ICRF-187 (ADR-529) in a chronic cardiotoxicity animal model. Cancer Res 52:194–201
3. Ali M, Kamjoo M, Thomas HD et al (2011) The clinically active PARP inhibitor AG014699 ameliorates cardiotoxicity but does not enhance the efficacy of doxorubicin, despite improving tumor perfusion and radiation response in mice. Mol Cancer Ther 10:2320–2329. doi:
10.1158/1535-7163.MCT-11-0356
4. Annunziata CM, O’Shaughnessy J (2010) Poly (ADP-ribose) polymerase as a novel therapeutic target in cancer. Clin Cancer Res 16:4517–4526. doi:
10.1158/1078-0432.CCR-10-0526
5. Aredia F, Scovassi AI (2014) Poly(ADP-ribose): a signaling molecule in different paradigms of cell death. Biochem Pharmacol. doi:
10.1016/j.bcp.2014.06.021
Cited by
199 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献